209 related articles for article (PubMed ID: 11146621)
1. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent.
Stenoien DL; Patel K; Mancini MG; Dutertre M; Smith CL; O'Malley BW; Mancini MA
Nat Cell Biol; 2001 Jan; 3(1):15-23. PubMed ID: 11146621
[TBL] [Abstract][Full Text] [Related]
2. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
3. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1.
Stenoien DL; Mancini MG; Patel K; Allegretto EA; Smith CL; Mancini MA
Mol Endocrinol; 2000 Apr; 14(4):518-34. PubMed ID: 10770489
[TBL] [Abstract][Full Text] [Related]
4. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
Bai Y; Giguére V
Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
[TBL] [Abstract][Full Text] [Related]
5. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
[TBL] [Abstract][Full Text] [Related]
6. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation.
Tsai HW; Katzenellenbogen JA; Katzenellenbogen BS; Shupnik MA
Endocrinology; 2004 Jun; 145(6):2730-8. PubMed ID: 15033909
[TBL] [Abstract][Full Text] [Related]
8. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta.
Tremblay GB; Tremblay A; Copeland NG; Gilbert DJ; Jenkins NA; Labrie F; Giguère V
Mol Endocrinol; 1997 Mar; 11(3):353-65. PubMed ID: 9058381
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells.
Stoner M; Saville B; Wormke M; Dean D; Burghardt R; Safe S
Mol Endocrinol; 2002 Oct; 16(10):2231-42. PubMed ID: 12351689
[TBL] [Abstract][Full Text] [Related]
10. Specific ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators.
Yan F; Gao X; Lonard DM; Nawaz Z
Mol Endocrinol; 2003 Jul; 17(7):1315-31. PubMed ID: 12663742
[TBL] [Abstract][Full Text] [Related]
11. Intranuclear mobility of estrogen receptor alpha and progesterone receptors in association with nuclear matrix dynamics.
Matsuda K; Nishi M; Takaya H; Kaku N; Kawata M
J Cell Biochem; 2008 Jan; 103(1):136-48. PubMed ID: 17541934
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity.
Schaaf MJ; Cidlowski JA
Mol Cell Biol; 2003 Mar; 23(6):1922-34. PubMed ID: 12612067
[TBL] [Abstract][Full Text] [Related]
13. Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm.
Devin-Leclerc J; Meng X; Delahaye F; Leclerc P; Baulieu EE; Catelli MG
Mol Endocrinol; 1998 Jun; 12(6):842-54. PubMed ID: 9626660
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of proteasome-dependent estrogen receptor alpha and beta turnover in cultured human uterine artery endothelial cells.
Tschugguel W; Dietrich W; Zhegu Z; Stonek F; Kolbus A; Huber JC
J Clin Endocrinol Metab; 2003 May; 88(5):2281-7. PubMed ID: 12727987
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation.
Fan M; Nakshatri H; Nephew KP
Mol Endocrinol; 2004 Nov; 18(11):2603-15. PubMed ID: 15284335
[TBL] [Abstract][Full Text] [Related]
16. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
17. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.
Smith CL; Nawaz Z; O'Malley BW
Mol Endocrinol; 1997 Jun; 11(6):657-66. PubMed ID: 9171229
[TBL] [Abstract][Full Text] [Related]
18. Proteasome-dependent degradation of the human estrogen receptor.
Nawaz Z; Lonard DM; Dennis AP; Smith CL; O'Malley BW
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1858-62. PubMed ID: 10051559
[TBL] [Abstract][Full Text] [Related]
19. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
Shah YM; Rowan BG
Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
[TBL] [Abstract][Full Text] [Related]
20. Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha.
Preisler-Mashek MT; Solodin N; Stark BL; Tyriver MK; Alarid ET
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E891-8. PubMed ID: 11882509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]